Wang Yao, Yan Ruikun, Ye Lijing, Tang Chao, Zhou Haibo, Zhao Guojun
Cardiovascular Medicine Department, Affiliated Qingyuan Hospital, Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, Guangdong Province, 511518, People's Republic of China.
College of Food Science and Engineering, Yangzhou University, Yangzhou, Jiangsu Province, 225127, People's Republic of China.
J Inflamm Res. 2025 Jun 18;18:8065-8084. doi: 10.2147/JIR.S505423. eCollection 2025.
Decoction (GQD), a traditional Chinese medicine formula, has shown significant therapeutic potential for colitis. However, the specific mechanisms by which GQD exerts its effects remain poorly understood, limiting its application in UC treatment.
In this study, we utilized a dextran sodium sulfate-induced colitis model in mice to evaluate the efficacy of GQD and to elucidate its underlying mechanisms.
Network pharmacology was employed to explore the potential targets and signaling pathways of GQD, which were subsequently validated using Western blot. The effects of GQD on gut barrier integrity, inflammation, and oxidative damage were assessed through immunofluorescence, immunohistochemistry, and ELISA. Additionally, 16S rRNA high-throughput sequencing was conducted to examine alterations in the gut microbiota composition.
The results demonstrated that GQD alleviated the colitis symptoms in mice, as evidenced by an increase in goblet cell numbers, upregulation of ZO-1, MUC-2, and Occludin expression, and a decrease in apoptosis in intestinal epithelial cells. GQD effectively suppressed the expression of pro-inflammatory and oxidative mediators, including interleukin-6, tumor necrosis factor-α, interleukin-1β, nitric oxide, malondialdehyde, and myeloperoxidase, with inhibition rates ranging from 47% to 66%. According to the results from Western blot, the phosphorylation levels of p53, Akt, STAT3, and MAPK inflammatory signaling pathway-related proteins (p38, ERK, and JNK) were significantly inhibited with GQD treatment. Furthermore, GQD re-regulated composition of gut microbiota, including inhibiting the harmful bacteria (, and ) enrichment and restoring the probiotics ( and ). The correlation analysis revealed that the abundances of gut microbiota were closely related to the key protein expression in colon.
This study revealed GQD can alleviate colitis by attenuating inflammation, restoring intestinal mucosal barrier and modulating gut microbiota.
中药复方灌肠剂(GQD)对结肠炎具有显著的治疗潜力。然而,GQD发挥作用的具体机制仍不清楚,这限制了其在溃疡性结肠炎(UC)治疗中的应用。
本研究利用葡聚糖硫酸钠诱导的小鼠结肠炎模型来评估GQD的疗效并阐明其潜在机制。
采用网络药理学探索GQD的潜在靶点和信号通路,随后用蛋白质免疫印迹法进行验证。通过免疫荧光、免疫组织化学和酶联免疫吸附测定法评估GQD对肠道屏障完整性、炎症和氧化损伤的影响。此外,进行16S rRNA高通量测序以检测肠道微生物群组成的变化。
结果表明,GQD减轻了小鼠的结肠炎症状,表现为杯状细胞数量增加、紧密连接蛋白1(ZO-1)、黏蛋白2(MUC-2)和闭合蛋白表达上调,以及肠上皮细胞凋亡减少。GQD有效抑制促炎和氧化介质的表达,包括白细胞介素-6、肿瘤坏死因子-α、白细胞介素-1β、一氧化氮、丙二醛和髓过氧化物酶,抑制率在47%至66%之间。蛋白质免疫印迹法结果显示,GQD处理后,p53、蛋白激酶B(Akt)、信号转导和转录激活因子3(STAT3)以及丝裂原活化蛋白激酶(MAPK)炎症信号通路相关蛋白(p38、细胞外信号调节激酶(ERK)和c-Jun氨基末端激酶(JNK))的磷酸化水平显著受到抑制。此外,GQD重新调节了肠道微生物群的组成,包括抑制有害菌( 、 和 )的富集并恢复益生菌( 和 )。相关性分析表明,肠道微生物群的丰度与结肠中的关键蛋白表达密切相关。
本研究表明,GQD可通过减轻炎症、恢复肠道黏膜屏障和调节肠道微生物群来缓解结肠炎。